Recruiting

AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(45 sites)

Australia

Research Site, Melbourne

Research Site, Nedlands

Belgium

Research Site, Antwerp

Research Site, Brussels

Research Site, Ghent

Research Site, Leuven

Research Site, Roeselare

Research Site, Yvoir

Brazil

Research Site, Porto Alegre

Research Site, São Paulo

Canada

Research Site, Calgary, Alberta

Research Site, Ottawa, Ontario

China

Research Site, Beijing

Research Site, Changchun

Research Site, Chengdu

Research Site, Guangzhou

Research Site, Jinan

Research Site, Nanchang

Research Site, Shanghai

Hong Kong

Research Site, Hong Kong

Research Site, Lai Chi Kok

Research Site, Shatin

Japan

Research Site, Bunkyō City

Research Site, Kōtoku

Research Site, Matsumoto-shi

Research Site, Meguro-ku

Research Site, Osaka

Research Site, Sunto-gun

Research Site, Yamagata

Research Site, Yokohama

Poland

Research Site, Kielce

Research Site, Krakow

Research Site, Lodz

Research Site, Lublin

Research Site, Wroclaw

South Korea

Research Site, Seoul

Turkey (Türkiye)

Research Site, Ankara

Research Site, Antalya

United Kingdom

Research Site, Glasgow, Scotland

Research Site, London

Research Site, Newcastle upon Tyne

Research Site, Nottingham